Pharmaceutical
Neuro-Innovators is a clinical-stage drug company focused on engineering drugs to accelerate brain neuroplasticity (i.e., the capacity of the brain to remodel, rewire, and recover) for patients suffering with brain injuries and diseases. For our first neuroplasticity target, we have created a combinational drug designed for patients with chronic motor deficits from stroke (Chronic Stroke). Our three-drug combination (NIV-001) is designed to increase brain plasticity via multiple mechanisms of action or pathways within the brain. Historically, stroke patients have undergone repetitive exercise and stimulation therapies to help restore some functions. While those therapies help, most patients are still left with clinical deficits in motion, speech, cognition, and other critical functions. NIV-001 is a pharmacological solution to be used in conjunction with physical therapies to improve patient outcomes significantly.